In this respect, MAO-A inhibitors have been used for decades for the treatment of depression and anxiety disorders while MAO-B inhibitors are used for Parkinson’s disease therapy, often in combination with levodopa, the metabolic precursor of dopamine [5]. This evidence concerns the gene MAOB and Parkinson disease.